| Autor: |
Shishkova VN; National Medical Research Center for Therapy and Preventive Medicine, Moscow, Russia., Imamgayazova KE; National Medical Research Center for Therapy and Preventive Medicine, Moscow, Russia., Kapustina LA; National Medical Research Center for Therapy and Preventive Medicine, Moscow, Russia. |
| Jazyk: |
ruština |
| Zdroj: |
Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova [Zh Nevrol Psikhiatr Im S S Korsakova] 2022; Vol. 122 (5), pp. 63-68. |
| DOI: |
10.17116/jnevro202212205163 |
| Abstrakt: |
This review discusses the importance of the main psychosocial risk factors in the development of chronic non-communicable diseases. The current data on the prevalence of anxiety and depressive disorders in patients with cardiovascular diseases (CVD) are presented. The article summarizes information about the relationship between the development of psychoemotional disorders and CVD, discusses the prospects for the management of such patients in the framework of interdisciplinary cooperation. The main pathogenetic mechanisms of the development of complications, including damage to the central nervous system during infection with a new coronavirus infection, are considered. The significance of the choice of pathogenetic therapy for patients with comorbid somatic and mental diseases in the conditions of a pandemic of a new coronavirus infection is assessed. The results of multicenter placebo-controlled studies on the use of fluvoxamine in patients with a new coronavirus infection of varying severity are discussed. |
| Databáze: |
MEDLINE |
| Externí odkaz: |
|
